Skip to main content
logo
Terumo Corporation (TYO:4543)
Japan flag Japan · Delayed Price · Currency is JPY
2,277.50
+15.00 (0.66%)
Jan 6, 2026, 3:30 PM JST

Revenue by Geography

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 20222011 - 2021
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 2011 - 2021
Americas Revenue
412.12B395.65B
Log In
Log In
Log In
Upgrade
Europe Revenue
226.53B218.29B
Log In
Log In
Log In
Upgrade
China Revenue
85.52B84.97B
Log In
Log In
Log In
Upgrade
Asia and Others Revenue
118.09B120.05B
Log In
Log In
Log In
Upgrade
Japan Revenue
220.16B217.21B
Log In
Log In
Log In
Upgrade

Revenue

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 20222011 - 2021
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 2011 - 2021
Cardiac and Vascular Company Revenue
640.15B624.36B
Log In
Log In
Log In
Upgrade
Medical Care Solutions Company Revenue
212.60B211.24B
Log In
Log In
Log In
Upgrade
Blood and Cell Technologies Company Revenue
209.35B200.28B
Log In
Log In
Log In
Upgrade
Adjustments from Revenue
329.00M298.00M
Log In
Log In
Log In
Upgrade

Adjusted EBIT

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 20222011 - 2021
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 2011 - 2021
Cardiac and Vascular Company Adjusted Operating Profit
164.82B154.68B
Log In
Log In
Log In
Upgrade
Medical Care Solutions Company Adjusted Operating Profit
23.78B22.99B
Log In
Log In
Log In
Upgrade
Blood and Cell Technologies Company Adjusted Operating Profit
28.91B26.48B
Log In
Log In
Log In
Upgrade
Adjustments from Adjusted Operating Profit
-3.65B-712.00M
Log In
Log In
Log In
Upgrade

Key Performance Indicators

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222011 - 2021
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 2011 - 2021
Cardiac and Vascular Company Production Result
620.90B
Log In
Log In
Log In
Upgrade
Medical Care Solutions Company Production Result
197.08B
Log In
Log In
Log In
Upgrade
Blood and Cell Technologies Company Production Result
205.67B
Log In
Log In
Log In
Upgrade
Total Production Result
1.02T
Log In
Log In
Log In
Upgrade
Updated Sep 30, 2025. Data Source: Fiscal.ai.